AzTrials
AzTrials

Smartphone AddictionVALSCREENNCT05585723

French Language Validation of Questionnaires for the Evaluation of Problematic Screen Use.

An observational study of Smartphone Addiction, run by University Hospital, Grenoble.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The main objective of this research is to linguistically validate the Smartphone Addiction Scale, Nomophobia Questionnaire, The Problematic Use of Mobile Phones scale, Smartphone Addiction Proneness Scale, Digital Addiction Scale for Children, Gaming Motivation Scale and Problematic Media Use Measure in French so that… Read more about this study

Who is it for?
Ages 12 to 25 yearsHealthy volunteers can take part
Conditions the study is for
Smartphone Addiction
What is being tested?
Questionnaires completion
How many people
40 participants
Where
No sites listed yet
Study dates
1 Nov 2022to 1 Jan 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: University students, teenagers and parents of teenagers to test understanding of linguistic validation of questionnaires

Who may be able to join

  • Inclusion criteria for the SAS, NMP-Q, SAPS questionnaires
  • University students over 18 years of age Inclusion criteria for the GAMS questionnaire
  • University students over 18 years of age
  • Video game players (at least one video game session in the past two weeks) Inclusion criteria for the PUMP and DASC questionnaires
  • Adolescents (12-17 years old) Inclusion criteria for the PMUM-SF questionnaire
  • Parents of adolescents (this can be parents of adolescents who answered the previous questions)
  • Adolescents must have access to at least one screen: smartphone, computer, television, etc (even that of a parent)

Who cannot join

  • Difficulties in understanding the French language
  • Cognitive disorders
  • Subject under guardianship or subject deprived of liberty
  • Opposition to participation in the study

Trial locations and contacts

No sites are listed yet.

Alexandre BELLIER, MD, PhD contact

+33476637149

abellier@chu-grenoble.fr

About this study

The main objective of this research is to linguistically validate the Smartphone Addiction Scale, Nomophobia Questionnaire, The Problematic Use of Mobile Phones scale, Smartphone Addiction Proneness Scale, Digital Addiction Scale for Children, Gaming Motivation Scale and Problematic Media Use Measure in French so that they are conceptually equivalent to their original version.

Being tested
Questionnaires completion
Medical subject headings
Internet Addiction Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaires completionBehavioural

    Prospective, qualitative, observational, single-center study. 1) Two independent translations of the original questionnaires into French, 2) Back-translation of the consensus version into English by a professional bilingual translator 3) We will submit this final version to two opinion leaders in France. 4) Evaluation of the clarity, comprehension and acceptability of the translation of the questionnaire.

Study groups in NCT05585723
Study groupRoleWhat they receive
students at the universityNot described
Receives: Behavioral: Questionnaires completion
teenagersNot described
Receives: Behavioral: Questionnaires completion
parents of teenagersNot described
Receives: Behavioral: Questionnaires completion

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The process of validation will be performed by the forward/backward method (Epstein et al. 2015). The translation will be considered valid when the tests performed by the participants are considered successful.

    Measured: through questionnaires completion, an average of 1 day

Secondary outcomes (1)
  1. Evaluation of the internal consistency of the questionnaires after cross-cultural adaptation in French language

    Measured: through questionnaires completion, an average of 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Oct 2022
  2. Study start1 Nov 2022 (estimated)
  3. Primary completion1 Dec 2022 (estimated)
  4. Study completion1 Jan 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05585723
Sponsor's protocol ID
2022-A01943-40
Acronym
VALSCREEN
Status last verified
Oct 2022
First submitted
10 Oct 2022
Last updated
19 Oct 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Smartphone Addiction, run by University Hospital, Grenoble.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Alexandre BELLIER, MD, PhD (+33476637149, abellier@chu-grenoble.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The process of validation will be performed by the forward/backward method (Epstein et al. 2015). The translation will be considered valid when the tests performed by the participants are considered successful. (time frame: through questionnaires completion, an average of 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in